Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 0 | 2 |
| Cost of Goods | N/A | N/A | N/A | N/A | 132 |
| Gross Profit | N/A | N/A | N/A | N/A | -131 |
| Operating Expenses | 17,265 | 11,434 | 7,649 | 7,969 | 12,760 |
| Operating Income | -17,265 | -11,434 | -7,649 | -7,969 | -12,759 |
| Other Income | 26 | 29 | -473 | 1,600 | 0 |
| Pre-tax Income | -17,240 | -11,405 | -8,123 | -6,369 | -12,758 |
| Net Income Continuous | -17,240 | -11,405 | -8,123 | -6,369 | -12,758 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -3,002 |
| Net Income | $-17,240 | $-11,405 | $-8,123 | $-6,369 | $-15,760 |
| EPS Basic Total Ops | -2.03 | -5.50 | -10.97 | -25.93 | -99.76 |
| EPS Basic Continuous Ops | -2.03 | -2.74 | -8.33 | -25.94 | -80.79 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -18.97 |
| EPS Diluted Total Ops | -2.03 | -5.50 | -10.97 | -25.93 | -99.76 |
| EPS Diluted Continuous Ops | -2.03 | -2.74 | -8.33 | -25.94 | -80.79 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -18.97 |
| EPS Diluted Before Non-Recurring Items | -2.03 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-17,213 | $-11,390 | $-7,520 | $-7,665 | $-12,486 |